IF YOU MEET ANY OF THESE INDICATIONS, PLEASE CONTACT US AT
strong>800 390 390
Prostate cancer
Reveals the risk of prostate cancer
Genetic analysis that can confirm or exclude a high risk of prostate cancer, which is one of the most frequently diagnosed cancers in men in the Czech Republic. Nearly eight thousand new cases are diagnosed annually. It is a cancer for which hereditary predispositions are a significant risk factor. Some of these cancers are caused by inherited cancer predispositions in risk genes. The result of the analysis will give you an answer as to whether you are at increased risk of developing this disease and, if necessary, allow you to take the necessary measures in time.
IN WHICH SITUATIONS IT IS APPROPRIATE TO TAKE THE TEST
PUBLIC HEALTH INSURANCE COVERS THE TEST IN THE FOLLOWING SITUATIONS
When testing for prostate cancer is covered by public health insurance:
Testing indications for prostate cancer:
- Incidence of ≥ 2 cases of prostate cancer in personal or family history, with at least one at age ≤ 55 years.
- ≥ 3 cases of prostate cancer in close relatives, death due to prostate cancer.
- Prostate cancer (Gleason score ≥ 7) or primary metastatic prostate cancer and ≥ 1 case of breast cancer, ovarian cancer, endometrial cancer, bowel or stomach cancer, renal cell carcinoma, malignant melanoma, pancreatic cancer, bladder cancer, gallbladder cancer.
If the relative who was diagnosed with cancer is no longer living, testing according to the above criteria is possible for first-degree relatives, with a family history on the mother's side for second-degree ones.
If you have a personal and/or family history of other cancers (colon or small bowel cancer, uterine cancer, kidney cancer, etc.), the genetic analysis may also be covered by public health insurance after a risk assessment by a clinical geneticist.
Schedule a genetic consultation.
DETAILED INFORMATION
Compared to patients without genetic predisposition, hereditary prostate cancer is often diagnosed at a younger age, the disease course may be more aggressive and the survival time shorter. People of reproductive age with a proven gene mutation can be offered preimplantation diagnosis as part of the IVF and prevent transmission of the risk disposition to the next generation by selecting a suitable embryo.
Men with a mutation in the BRCA2 gene have up to a 20% higher lifetime risk of prostate cancer. Targeted prevention of this disease is therefore very important, as prostate tumours grow slowly and with early diagnosis there is a good chance of a complete cure.
Genetic analysis examines mutations in the BRCA1, BRCA2, CHEK2, HOXB13, ATM genes. In case of a positive finding, genetic consultation and predictive testing of the patient's blood relatives is recommended.
HOW THE TEST WORKS AND WHAT YOU CAN EXPECT
After ordering the test, you will receive an email with detailed information. A DNA sample is most often obtained through an oral swab or blood sample. You can perform the oral swab yourself in the comfort of your own home using a collection kit, which will be sent to you by mail together with instructions and other documents. You can have your blood drawn at your local physician's office or at our outpatient clinic. The result of the analysis will be sent to you by e-mail or by post as agreed. In case of a positive result, we will arrange a consultation with a clinical geneticist who will explain everything and recommend appropriate measures.